| PERIOD ENDING | 31-Dec-09 | 2-Oct-09 | 3-Jul-09 | 31-Mar-09 | | Total Revenue | 6,556,137 | 5,831,761 | 5,782,679 | 5,582,524 | | Cost of Revenue | 6,108,949 | 5,532,181 | 5,558,684 | 5,473,661 | | | Gross Profit | 373,052 | 299,580 | 223,995 | 108,863 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 205,613 | 68,847 | 309,091 | 195,825 | | Non Recurring | 162 | 187 | 12,730 | 105,192 | | Others | 21,440 | 22,710 | 23,334 | 27,696 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 145,837 | 207,836 | (121,160) | (219,850) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
| (199,398) |
-
| 9,310 | | Earnings Before Interest And Taxes | 30,304 | 8,438 | (121,160) | (210,540) | | Interest Expense | (74,977) | 38,091 | 36,886 | 47,115 | | Income Before Tax | 105,281 | (29,653) | (158,046) | (257,655) | | Income Tax Expense | 12,411 | (49,312) | (4,003) | (17,858) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 92,870 | 19,659 | (154,043) | (239,797) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 92,870 | 19,659 | (154,043) | (239,797) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $92,870 | $19,659 | ($154,043) | ($239,797) |
|
1.52% Nasdaq 0.00%
Income Statement
